Callan Family Office’s Bristol-Myers Squibb BMY Stock Holding History

Callan Family Office's BMY Position: Q1 2026 in Review

Callan Family Office increased its Bristol-Myers Squibb (BMY) stake by 41% in Q1 2026, buying an estimated $771K and bringing the position to 45,226 shares worth $2.74M. The position accounts for 0.06% of the portfolio, ranked #290.

Callan Family Office first reported a position in BMY in Q1 2023 and has held it in 8 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

• Callan Family Office held 45,226 shares of Bristol-Myers Squibb worth $2.74M as of Q1 2026.
• Callan Family Office bought 13,218 Bristol-Myers Squibb shares in Q1 2026, an estimated $771K.
• Bristol-Myers Squibb made up 0.06% of Callan Family Office's portfolio in Q1 2026, its #290 holding.
• Callan Family Office first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 8 quarters since.
• 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.